Last updated on March 2019

XIENCE Xpedition/Alpine in Routine Clinical Practice


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Percutaneous Transluminal Coronary Angioplasty | Coronary Artery Disease | Coronary heart disease
  • Age: Between 19 - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Age 19 and more
  • Intervention with XIENCE Xpedition or Alpine everolimus eluting coronary stent
  • Agreed with written informed consent form

Exclusion Criteria:

  • Intervention with XIENCE Xpedition or Alpine everolimus eluting coronary stent and other drug eluting stent at the same time
  • Life expectancy of 1year and under
  • Cardiac shock

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.